2020-2029 Report on Global Biosimilar Drug Market by Player, Region, Type, Application and Sales Channel
- Report Code : MAR2022489
- Published On: Sep, 2020
- Category : Healthcare & Pharma
- Pages : 121
-
The global Biosimilar Drug market was valued at $XX million in 2019, and Research analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020.
This report analyses the impact of COVID-19 on this industry. COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on enterprises and financial markets.
This report provides detailed historical analysis of global market for Biosimilar Drug from 2014-2019, and provides extensive market forecasts from 2020-2029 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Biosimilar Drug market.
Leading players of Biosimilar Drug including:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Market split by Type, can be divided into:
Injection
Tablets
Other Types
Market split by Application, can be divided into:
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
-
With tables and figures helping analyze worldwide Report on Global Biosimilar Drug Market by Player market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Chapter 1 Biosimilar Drug Market Overview1.1 Biosimilar Drug Definition
1.2 Global Biosimilar Drug Market Size Status and Outlook (2014-2029)
1.3 Global Biosimilar Drug Market Size Comparison by Region (2014-2029)
1.4 Global Biosimilar Drug Market Size Comparison by Type (2014-2029)
1.5 Global Biosimilar Drug Market Size Comparison by Application (2014-2029)
1.6 Global Biosimilar Drug Market Size Comparison by Sales Channel (2014-2029)
1.7 Biosimilar Drug Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Biosimilar Drug Market Segment Analysis by Player2.1 Global Biosimilar Drug Sales and Market Share by Player (2017-2019)
2.2 Global Biosimilar Drug Revenue and Market Share by Player (2017-2019)
2.3 Global Biosimilar Drug Average Price by Player (2017-2019)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biosimilar Drug Market Segment Analysis by Type3.1 Global Biosimilar Drug Market by Type
3.1.1 Injection
3.1.2 Tablets
3.1.3 Other Types3.2 Global Biosimilar Drug Sales and Market Share by Type (2014-2019)
3.3 Global Biosimilar Drug Revenue and Market Share by Type (2014-2019)
3.4 Global Biosimilar Drug Average Price by Type (2014-2019)
3.5 Leading Players of Biosimilar Drug by Type in 2019
3.6 Conclusion of Segment by Type
Chapter 4 Biosimilar Drug Market Segment Analysis by Application4.1 Global Biosimilar Drug Market by Application
4.1.1 Ankylosing Spondylitis
4.1.2 Tumor
4.1.3 Rheumatoid Arthrtis
4.1.4 Cardiovascular
4.1.5 Other Application4.2 Global Biosimilar Drug Sales and Market Share by Application (2014-2019)
4.3 Leading Consumers of Biosimilar Drug by Application in 2019
4.4 Conclusion of Segment by Application
Chapter 5 Biosimilar Drug Market Segment Analysis by Sales Channel5.1 Global Biosimilar Drug Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel5.2 Global Biosimilar Drug Sales and Market Share by Sales Channel (2014-2019)
5.3 Leading Distributors/Dealers of Biosimilar Drug by Sales Channel in 2019
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biosimilar Drug Market Segment Analysis by Region6.1 Global Biosimilar Drug Market Size and CAGR by Region (2014-2029)
6.2 Global Biosimilar Drug Sales and Market Share by Region (2014-2019)
6.3 Global Biosimilar Drug Revenue and Market Share by Region (2014-2019)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biosimilar Drug Market Share by Type
6.4.3 North America Biosimilar Drug Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biosimilar Drug Market Share by Type
6.5.3 Europe Biosimilar Drug Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biosimilar Drug Market Share by Type
6.6.3 Asia-Pacific Biosimilar Drug Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biosimilar Drug Market Share by Type
6.7.3 South America Biosimilar Drug Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biosimilar Drug Market Share by Type
6.8.3 Middle East & Africa Biosimilar Drug Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biosimilar Drug Players7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Roche7.2 Amgen
7.3 AbbVie
7.4 Sanofi-Aventis
7.5 Johnson & Johnson
7.6 Pfizer
7.7 Novo Nordisk
7.8 Eli Lilly
7.9 Novartis7.10 Merck
7.11 3sbio
7.12 Changchun High Tech
7.13 CP Guojian
7.14 Biotech
7.15 Gelgen
7.16 Innovent
7.17 Dong Bao
7.18 Ganlee
Chapter 8 Upstream and Downstream Analysis of Biosimilar Drug8.1 Industrial Chain of Biosimilar Drug
8.2 Upstream of Biosimilar Drug
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process8.3 Downstream of Biosimilar Drug
8.3.1 Leading Distributors/Dealers of Biosimilar Drug
8.3.2 Leading Consumers of Biosimilar Drug
Chapter 9 Development Trend of Biosimilar Drug (2020-2029)9.1 Global Biosimilar Drug Market Size (Sales and Revenue) Forecast (2020-2029)
9.2 Global Biosimilar Drug Market Size and CAGR Forecast by Region (2020-2029)
9.3 Global Biosimilar Drug Market Size and CAGR Forecast by Type (2020-2029)
9.4 Global Biosimilar Drug Market Size and CAGR Forecast by Application (2020-2029)
9.5 Global Biosimilar Drug Market Size and CAGR Forecast by Sales Channel (2020-2029)
Chapter 10 Appendix10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
-
The Report on Global Biosimilar Drug Market by Player Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Report on Global Biosimilar Drug Market by Player has a wide range of applications, including
During the projected year from 2024 to 2029, the Report on Global Biosimilar Drug Market by Player Market is expected to grow at a CAGR of xx%.
The Report on Global Biosimilar Drug Market by Player Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
In this highly competitive and rapidly evolving Report on Global Biosimilar Drug Market by Player Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.
